The Impact of COVID-19 is included in Next Generation Sequencing Market. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
The future of the next generation sequencing market looks promising with opportunities in academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. The global next generation sequencing market is expected to grow with a CAGR of 20% to 22% from 2021 to 2026. The major drivers for this market are government regulations and reimbursement for NGS-based diagnostic tests, advancements in NGS platforms, and declining costs of NGS tests.
A more than 150 page report is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of next generation sequencing market report download the report brochure.
The study includes trends and forecasts for the global next generation sequencing market by product & service, technology, application, end user, and region as follows:
By Product & Service [$M shipment analysis for 2015 – 2026]:
-
Presequencing Products & Services
-
NGS consumables
-
NGS Platforms
-
Services for NGS Platforms
-
Sequencing Services
-
Bioinformatics
By Technology [$M shipment analysis for 2015 – 2026]
-
Sequencing by Synthesis
-
Ion Semiconductor Sequencing
-
Single-molecule Real-time Sequencing
-
Nanopore Sequencing
-
Other Sequencing Technologies
By Application [$M shipment analysis for 2015 – 2026]:
-
Diagnostics
-
Drug Discovery
-
Agriculture & Animal Research
-
Other Applications
By End User [$M shipment analysis for 2015 – 2026]:
-
Academic Institutes & Research Centers
-
Hospitals & Clinics
-
Pharmaceutical & Biotechnology Companies
-
Other End Users
By Region [$M shipment analysis for 2015 – 2026]:
-
North America
-
United States
-
Canada
-
Mexico
-
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
The Rest of the World
Diagnostic application will remain the largest segment due to rising number of cancer cases across the world.
Academic institutes & research centers will remain the largest end user segment during the forecast period due to the development of cost-effective NGS products and services for researchers and increasing collaborations between academic institutes & research centers and NGS players.
North America will remain the largest region during the forecast period due to the investments in research funding, and development of NGS data analysis solutions.
Some of the next generation sequencing companies profiled in this report includes Illumina, Inc., Thermo Fisher Scientific, Inc. BGI Group, PerkinElmer Inc., Macrogen, Hamilton Company, Lucigen, Oxford Nanopore Technologies, Agilent Technologies, Inc., and QIAGEN.
Features of Next Generation Sequencing Market
|
-
Market Size Estimates: Next Generation Sequencing market size estimation in terms of value ($M)
-
Trend and Forecast Analysis: Market trends (2015-2020) and forecast (2021-2026) by various segments and regions.
-
Segmentation Analysis: Market size by product & service, technology, application and end user
-
Regional Analysis: Next Generation Sequencing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
-
Growth Opportunities: Analysis on growth opportunities in different end user, product & service, technology, application, and regions for next generation sequencing market.
-
Strategic Analysis: This includes M&A, new product development, and competitive landscape for the next generation sequencing market.
-
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
|
This report answers following 11 key questions |
Q.1 What are some of the most promising potential, high-growth opportunities for the global next generation sequencing market by product & service (presequencing products & services, NGS consumables, NGS platforms, services for NGS platforms, sequencing services, and bioinformatics), technology (sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies), application (diagnostics, drug discovery, agriculture & animal research, and other applications), end user (academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the next generation sequencing market?
Q.5 What are the business risks and threats to the next generation sequencing market?
Q.6 What are the emerging trends in the next generation sequencing market and the reasons behind them?
Q.7 What are some changing demands of customers in the next generation sequencing market?
Q.8 What are the new developments in the next generation sequencing market? Which companies are leading these developments?
Q.9 Who are the major players in the next generation sequencing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in the next generation sequencing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the next generation sequencing market? |